Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection

被引:7
|
作者
Pittman, Jessica E. [1 ]
Noah, Hannah
Calloway, Hollin E. [2 ,3 ,7 ]
Davis, Stephanie D.
Leigh, Margaret W. [5 ,7 ]
Drumm, Mitchell [2 ,3 ,4 ,7 ]
Sagei, Scott D. [4 ,5 ]
Accurso, Frank J. [5 ,6 ,7 ]
Knowles, Michael R. [3 ,4 ]
Sontag, Marci K. [2 ]
机构
[1] Washington Univ Sch Med, Div Pediat Allergy, Immunol, & Pulm Med, St Louis, MO USA
[2] Stanford Univ Sch Med, Dept Otolaryngol Head Neck Surg, Palo Alto, CA USA
[3] Indiana Univ Sch Med Riley Hosp Children, Sect Pediat Pulmonol, Allergy, & Sleep Med, Indianapolis, IN USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Univ N Carolina, Chapel Hill, NC USA
[6] Case Western Reserve Univ, Dept Pediat & Genet & Genome Sci, Cleveland, OH USA
[7] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
来源
PLOS ONE | 2017年 / 12卷 / 05期
关键词
RESISTANT STAPHYLOCOCCUS-AUREUS; LOWER AIRWAY INFLAMMATION; PULMONARY-FUNCTION; YOUNG-CHILDREN; FUNCTION DECLINE; STENOTROPHOMONAS-MALTOPHILIA; INHALED TOBRAMYCIN; RISK-FACTORS; DISEASE; OUTCOMES;
D O I
10.1371/journal.pone.0177215
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective Pseudomonas aeruginosa has been suggested as a major determinant of poor pulmonary outcomes in cystic fibrosis (CF), although other factors play a role. Our objective was to investigate the association of early childhood Pseudomonas infection on differences in lung function in adolescence with CF. Methods Two populations of subjects with CF were studied: from the Gene Modifier Study (GMS), 346 F508del homozygotes with severe vs. mild adolescent lung disease, and from the Colorado Newborn Screen Study (NBS) 172 subjects diagnosed with CF by newborn screening. Associations of Pseudomonas infection and lung function in early childhood with lung function in adolescence were investigated using multivariate linear regression analyses. Results Among GMS subjects, those with severe adolescent lung disease had worse lung function in childhood (FEV1 25 percentage points lower) compared to subjects with mild adolescent lung disease, regardless of early childhood Pseudomonas status. Among NBS subjects, those with lowest adolescent lung function had significantly lower early childhood lung function and faster rate of decline in FEV1 than subjects with highest adolescent lung function; early Pseudomonas infection was not associated with rate of FEV1 decline. The strongest predictor of adolescent lung function was early childhood lung function. Subjects with a higher percentage of cultures positive for Pseudomonas before age 6 or a lower BMI at 2-4 years old also had lower adolescent lung function, though these associations were not as strong as with early childhood lung function. Conclusions In separate analyses of two distinct populations of subjects with CF, we found a strong correlation between lower lung function in early childhood and adolescence, regardless of early childhood Pseudomonas status. Factors in addition to early Pseudomonas infection have a strong impact on lung function in early childhood in CF. Further exploration may identify novel underlying genetic or environmental factors that predispose children with CF to early loss of lung function.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection
    Pukhalsky, AL
    Kapranov, NI
    Kalashnikova, EA
    Shmarina, GV
    Shabalova, LA
    Kokarovtseva, SN
    Pukhalskaya, DA
    Kashirskaja, NJ
    Simonova, OI
    MEDIATORS OF INFLAMMATION, 1999, 8 (03) : 159 - 167
  • [32] Pseudomonas aeruginosa as an independent predictor of decreased lung function in bronchiectasis
    Da Costa, Joao Cordeiro
    Viana, Raquel
    Silva, Candida Goncalves
    Carvalho, Claudia
    Feijo, Salvato
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [33] STRUCTURE-FUNCTION RELATIONSHIPS IN EARLY CYSTIC FIBROSIS LUNG DISEASE
    Bayfield, K.
    Kennedy, B.
    Boyton, C.
    Fitzpatrick, R.
    Middleton, A.
    Weinheimer, O.
    Caplain, N.
    Wielputz, M.
    Yu, L.
    Galban, C.
    Robinson, T.
    Fitzgerald, D.
    Pandit, C.
    Towns, S.
    Bartholmai, B.
    King, G.
    Selvadurai, H.
    Robinson, P.
    RESPIROLOGY, 2020, 25 : 34 - 35
  • [34] Pulmonary Function Tests in the Evaluation of Early Lung Disease in Cystic Fibrosis
    Walicka-Serzysko, Katarzyna
    Postek, Magdalena
    Borawska-Kowalczyk, Urszula
    Milczewska, Justyna
    Sands, Dorota
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [35] Does newborn screening improve early lung function in cystic fibrosis?
    Davies, Gwyneth
    PAEDIATRIC RESPIRATORY REVIEWS, 2022, 42 : 17 - 22
  • [36] Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis
    Ren, Clement L.
    Konstan, Michael W.
    Yegin, Ashley
    Rasouliyan, Lawrence
    Trzaskoma, Benjamin
    Morgan, Wayne J.
    Regelmann, Warren
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (04) : 293 - 299
  • [37] T Cell Hyporesponsiveness To Pseudomonas AerugINOSa In Cystic Fibrosis Relates To Rate Of Lung Function Decline
    Bailey, E. P.
    Cernadas, M.
    Duan, B.
    Priebe, G. P.
    Gerard, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [38] Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection
    Giordano, A
    Magni, A
    Filadoro, F
    Graziani, C
    Quattrucci, S
    Cipriani, P
    MICROBIOLOGICA, 1998, 21 (04): : 375 - 378
  • [39] Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis
    Nixon, GM
    Armstrong, DS
    Carzino, R
    Carlin, JB
    Olinsky, A
    Robertson, CF
    Grimwood, K
    JOURNAL OF PEDIATRICS, 2001, 138 (05): : 699 - 704
  • [40] Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis
    Casaredi, Isabel Gascon
    Shaw, Michelle
    Waters, Valerie
    Seeto, Ryan
    Blanchard, Ana C.
    Ratjen, Felix
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (01) : 98 - 102